[HTML][HTML] Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised …

R Griesel, Y Zhao, B Simmons, Z Omar, L Wiesner… - The Lancet …, 2023 - thelancet.com
Background The drug–drug interaction between rifampicin and dolutegravir can be
overcome by supplemental dolutegravir dosing, which is difficult to implement in high …

[HTML][HTML] Dolutegravir once daily with Rifampicin for HIV and TB?

A Naidoo, KE Dooley - The lancet. HIV, 2023 - ncbi.nlm.nih.gov
The World Health Organization recommends dolutegravir in first-line antiretroviral drug
regimens for the treatment of HIV-1 infection. 1 In most settings, dolutegravir is given with …

Efficacy of raltegravir-based regimens for antiretroviral treatment of people with HIV and tuberculosis in low-and middle-income countries: insight from clinical trials

N De Castro - 2022 - theses.hal.science
In people with HIV (PWH) and tuberculosis, management of antiretroviral therapy (ART) is
complex due to drug-drug interactions between antiretrovirals and rifampicin, one of the …

[引用][C] DOCTEUR DE L'UNIVERSITÉ DE BORDEAUX

N De Castro